Edgewise Therapeutics, Inc. (NASDAQ:EWTX) IPO
IPO
Priced at US$16.00 a share on Mar 25, 2021.
- Price
- US$16.00 a share
- Shares offered
- 11,000,000 shares of common stock
- Offering size
- US$176 million
- Underwriters' option
- Up to 1,650,000 more shares
- Listing
- EWTX on the Nasdaq Global Select Market
- Underwriters
- J.P. Morgan, Goldman Sachs & Co. LLC, SVB Leerink, Wedbush PacGrow · In the order on the cover
- Shares delivered
- On or about Mar 30, 2021
Steps
| Step | When |
|---|---|
| Draft sent to the SEC in confidence | Dec 18, 2020 |
| Filed publicly | Mar 5, 2021 |
| Amended twice | Newest Mar 24, 2021 |
| Shares registered with an exchange | Mar 17, 2021 |
| Declared effective by the SEC | Mar 25, 2021 |
| Final prospectus, with the price | Mar 26, 2021 |
Filings
| Filing | Filed |
|---|---|
| 424B4 · Prospectus | Mar 26, 2021 |
| EFFECT · Notice that a registration is effective | Mar 25, 2021 |
| S-1MEF · Registration of more shares for the same offering | Mar 25, 2021 |
| CERT · Exchange's certificate of listing | Mar 25, 2021 |
| S-1/A · Registration statement, amended | Mar 24, 2021 |
| CORRESP · Letter to the SEC | Mar 22, 2021 |
| CORRESP · Letter to the SEC | Mar 22, 2021 |
| S-1/A · Registration statement, amended | Mar 22, 2021 |
| 8-A12B · Registration of shares for listing on an exchange | Mar 17, 2021 |
| CORRESP · Letter to the SEC | Mar 8, 2021 |
| S-1 · Registration statement | Mar 5, 2021 |
| DRS/A · Draft registration statement, amended | Mar 2, 2021 |
| DRS/A · Draft registration statement, amended | Jan 25, 2021 |
| DRSLTR · Letter to the SEC with a draft | Jan 22, 2021 |
| UPLOAD · Letter from the SEC | Jan 12, 2021 |
| DRS · Draft registration statement | Dec 18, 2020 |
From the cover of the final prospectus (424B4) filed Mar 26, 2021